Skip to content

Compliance and Cumulative Interceptive Rate After Therapy of Peri-implantitis

Compliance Rate After Therapy of Peri-implantitis: Retrospective Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05772078
Enrollment
140
Registered
2023-03-16
Start date
2023-07-01
Completion date
2023-10-30
Last updated
2024-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peri-Implantitis

Brief summary

Peri-implantitis is a plaque-mediated inflammatory condition featured by progressive bone loss. This entity jeopardizes the longevity of dental implants, thus impacting negatively on the quality of life of patients. Moreover, peri-implantitis is suggested to lead to an increased systemic status of inflammation. This may rise the susceptibility to experience life-threating conditions. Therefore, peri-implant infections must be promptly diagnosed and eliminated. Aiming at resolving the inflammation, several options are advised to remove the infection. Accordingly, implant removal or therapeutic manoeuvres to stablish a healthy ecosystem in the peri-implant environment have been suggested. While the former proved being more predictable, the later demonstrated being more conservative. Indeed, implant removal is commonly associated with regenerative procedures of the alveolar bone deformity that often demand time and is more costly. Anyways, disease severity, implant expendability for biomechanical reasons or esthetic demand seem to be few of the leading aspects in the decision-making process on maintaining or extracting implant showing peri-implant lesions. Supportive maintenance care (SPT) was shown to be key in preventing disease recurrence. Nonetheless, the compliance of these patients is often erratic. In fact, it is yet unknown the rate of compliance after therapy. Therefore, the goal of this study is to assess the rate and confounders for compliance.

Interventions

OTHERAssess compliance rate and demographics

Records to evaluate attendance rate

Sponsors

Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients that underwent treatment of peri-implantitis * \>12 months of follow-up after therapy * Patients managed in our center

Exclusion criteria

* Patients that were managed in other centers * Patients that have incomplete records

Design outcomes

Primary

MeasureTime frameDescription
Compliance rate1 to 6 years of follow-upHow many patients are complete compliers

Secondary

MeasureTime frameDescription
Demographics1 to 6 years of follow-upEvaluate the patient-related features affecting compliance

Other

MeasureTime frameDescription
Cumulative Interceptive Rate1 to 6 years of follow-upoInterventions needed after active therapy to manage peri-implantitis during supportive peri-implant care for erratic and regular compliers

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026